Company Filing History:
3 out of 441 
1 out of 15 Years Active: 2020-2024
Title: Kazuki Satoh: Innovator in Tumor Therapy and Autoimmune Disease Detection
Introduction
Kazuki Satoh is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of tumor therapy and autoimmune disease detection. With a total of 4 patents, his work focuses on innovative solutions that address critical health challenges.
Latest Patents
One of Satoh's latest patents is an Anti-GARP antibody. This invention relates to an antibody that binds to GARP and is useful as a therapeutic agent for tumors. The antibody inhibits the function of regulatory T-cells (Treg) in tumors, providing a pharmaceutical product with therapeutic effects. Additionally, it includes a method for treating tumors using this antibody. Another notable patent involves in-vitro methods for detecting autoimmune diseases or conditions. This method measures the expression levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) in activated CD4+ T-cells, particularly in patients with relapsing remitting multiple sclerosis. The invention offers a screening method for detecting autoimmune diseases by comparing gene expression profiles from Treg-resistant and Treg-sensitive CD4+ T-cells.
Career Highlights
Kazuki Satoh has worked with notable organizations, including Daiichi Sankyo Company, Limited and Universitätsmedizin der Johannes Gutenberg-Universität Mainz. His experience in these institutions has contributed to his expertise in the medical and pharmaceutical fields.
Collaborations
Throughout his career, Satoh has collaborated with esteemed colleagues such as Kazuki Hirahara and Ichiro Watanabe. These partnerships have further enhanced his research and development efforts.
Conclusion
Kazuki Satoh's innovative work in tumor therapy and autoimmune disease detection showcases his commitment to advancing medical science. His patents reflect a dedication to improving therapeutic options for patients, making him a significant figure in the field of biomedical research.